Skip to main content
Premium Trial:

Request an Annual Quote

Cytochroma

Premium

Nascent drug maker Cytochroma, of Markham, Ontario, which focuses on identifying small molecules that target cytochrome P450 gene mutations, said it has uncovered a gene that metabolizes 9-cis retinoic acid.

The gene, CYP26C, is generally understood to be the third member of the CYP450 gene family, which metabolize all-trans retinoic acid. The other two genes, CYP26A and CYP26B, do not do this.

So far, Cytochroma CSO Martin Petkovich has published a study showing that CYP26A is expressed in murine embryonic hindbrain, inner ear, and tooth buds.

The company said it is currently looking for partners to develop the discovery.

Filed under

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.